Rafiq Hasan is the founder of Complement Therapeutics. Complement Therapeutics has raised $5M in total funding. Latest round: Seed.
Dr. Rafiq Hasan is the CEO of Complement Therapeutics, a biotechnology company focused on next-generation complement therapeutics. He was appointed CEO when the company emerged from stealth mode in 2021, at which point it raised EUR 5 million in seed financing.
Full founder directory · Investor directory · Company funding database · Fundraising library